These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 29313067)

  • 41. Assessment of HDACi-Induced Protein Cleavage by Caspases.
    Treude F; Gladbach T; Plaster J; Hartkamp J
    Methods Mol Biol; 2017; 1510():11-22. PubMed ID: 27761810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histone deacetylase inhibitors induce proteolysis of activated CDC42-associated kinase-1 in leukemic cells.
    Mahendrarajah N; Paulus R; Krämer OH
    J Cancer Res Clin Oncol; 2016 Nov; 142(11):2263-73. PubMed ID: 27576506
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination Effect of Silver Nanoparticles and Histone Deacetylases Inhibitor in Human Alveolar Basal Epithelial Cells.
    Gurunathan S; Kang MH; Kim JH
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30111752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors.
    Kortenhorst MS; Wissing MD; Rodríguez R; Kachhap SK; Jans JJ; Van der Groep P; Verheul HM; Gupta A; Aiyetan PO; van der Wall E; Carducci MA; Van Diest PJ; Marchionni L
    Epigenetics; 2013 Sep; 8(9):907-20. PubMed ID: 23880963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer.
    Torres-Adorno AM; Lee J; Kogawa T; Ordentlich P; Tripathy D; Lim B; Ueno NT
    Clin Cancer Res; 2017 Aug; 23(16):4780-4792. PubMed ID: 28465444
    [No Abstract]   [Full Text] [Related]  

  • 46. Histone Deacetylase Inhibitors (HDACi) Cause the Selective Depletion of Bromodomain Containing Proteins (BCPs).
    Mackmull MT; Iskar M; Parca L; Singer S; Bork P; Ori A; Beck M
    Mol Cell Proteomics; 2015 May; 14(5):1350-60. PubMed ID: 25755299
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-leukemia activity of MS-275 histone deacetylase inhibitor implicates 4-1BBL/4-1BB immunomodulatory functions.
    Vire B; de Walque S; Restouin A; Olive D; Van Lint C; Collette Y
    PLoS One; 2009 Sep; 4(9):e7085. PubMed ID: 19759901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models.
    Shen L; Ciesielski M; Ramakrishnan S; Miles KM; Ellis L; Sotomayor P; Shrikant P; Fenstermaker R; Pili R
    PLoS One; 2012; 7(1):e30815. PubMed ID: 22303460
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histone deacetylase (HDAC) inhibitor kinetic rate constants correlate with cellular histone acetylation but not transcription and cell viability.
    Lauffer BE; Mintzer R; Fong R; Mukund S; Tam C; Zilberleyb I; Flicke B; Ritscher A; Fedorowicz G; Vallero R; Ortwine DF; Gunzner J; Modrusan Z; Neumann L; Koth CM; Lupardus PJ; Kaminker JS; Heise CE; Steiner P
    J Biol Chem; 2013 Sep; 288(37):26926-43. PubMed ID: 23897821
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Entinostat for treatment of solid tumors and hematologic malignancies.
    Knipstein J; Gore L
    Expert Opin Investig Drugs; 2011 Oct; 20(10):1455-67. PubMed ID: 21888556
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vorinostat induces reactive oxygen species and DNA damage in acute myeloid leukemia cells.
    Petruccelli LA; Dupéré-Richer D; Pettersson F; Retrouvey H; Skoulikas S; Miller WH
    PLoS One; 2011; 6(6):e20987. PubMed ID: 21695163
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-kappaB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activation.
    Dai Y; Rahmani M; Dent P; Grant S
    Mol Cell Biol; 2005 Jul; 25(13):5429-44. PubMed ID: 15964800
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK Pathways.
    Sampson VB; Vetter NS; Kamara DF; Collier AB; Gresh RC; Kolb EA
    PLoS One; 2015; 10(11):e0142704. PubMed ID: 26571493
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dual-function antiandrogen/HDACi hybrids based on enzalutamide and entinostat.
    Barrett RRG; Nash C; Diennet M; Cotnoir-White D; Doyle C; Mader S; Thomson AA; Gleason JL
    Bioorg Med Chem Lett; 2022 Jan; 55():128441. PubMed ID: 34767912
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA).
    Mehdi O; Françoise S; Sofia CL; Urs G; Kevin Z; Bernard S; Igor S; Anabela CD; Dominique L; Eric M; Ali O
    Pancreatology; 2012; 12(2):146-55. PubMed ID: 22487525
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells.
    You BR; Han BR; Park WH
    Oncotarget; 2017 Mar; 8(11):17726-17737. PubMed ID: 28099148
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radioresistant Sf9 insect cells readily undergo an intrinsic mode of apoptosis in response to histone deacetylase (HDAC) inhibition.
    Kumar JS; Suman S; Chandna S
    Mol Cell Biochem; 2018 Jul; 444(1-2):207-218. PubMed ID: 29236219
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An intact immune system is required for the anticancer activities of histone deacetylase inhibitors.
    West AC; Mattarollo SR; Shortt J; Cluse LA; Christiansen AJ; Smyth MJ; Johnstone RW
    Cancer Res; 2013 Dec; 73(24):7265-76. PubMed ID: 24158093
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of the interplay between all-trans retinoic acid and histone deacetylase inhibitors in leukemic cells.
    Noack K; Mahendrarajah N; Hennig D; Schmidt L; Grebien F; Hildebrand D; Christmann M; Kaina B; Sellmer A; Mahboobi S; Kubatzky K; Heinzel T; Krämer OH
    Arch Toxicol; 2017 May; 91(5):2191-2208. PubMed ID: 27807597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rosmarinic Acid, a Component of Rosemary Tea, Induced the Cell Cycle Arrest and Apoptosis through Modulation of HDAC2 Expression in Prostate Cancer Cell Lines.
    Jang YG; Hwang KA; Choi KC
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.